Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Liposomal Cytarabine in Combination With Radiotherapy (RT) and Lomustine for the Treatment of Leptomeningeal Metastasis From Malignant Melanoma

NCT01563614 is registered in ClinicalTrials.gov with University Hospital, Bonn as lead sponsor.

NCT NCT01563614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01563614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Liposomal Cytarabine in Combination With Radiotherapy (RT) and Lomustine for the Treatment of Leptomeningeal Metastasis From Malignant Melanoma
Lead sponsor
University Hospital, Bonn
Phase
Phase 1
Overall status
Terminated
Start date
March 31, 2012
Completion date
November 30, 2015
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leptomeningeal metastasis from malignant melanoma